Summary of findings table ‐ Recombinant activated factor VII vs placebo/open control
Death or dependence (mRS 4 to 6) at day 90 · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Recombinant activated factor VII showed no clear difference in death or dependence (mRS 4–6) compared with placebo/open control (low certainty).
1 finding from 1 review
- Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage 2023 · Cochrane Headline outcomes onlyRR 0.88 [0.74, 1.05]7 studies · 1454 participantsLow